Citation 116034

AMOROS,M: SIMOES,CMO: GIRRE,L: SAUVAGER,F: CORMIER,M:. (1992). SYNERGISTIC EFFECT OF FLAVONES AND FLAVONOLS AGAINST HERPES SIMPLEX VIRUS TYPE 1 IN CELL CULTURE. COMPARISON WITH THE ANTIVIRAL ACTIVITY OF PROPOLIS.. 55(12)

Citation Details

Title	SYNERGISTIC EFFECT OF FLAVONES AND FLAVONOLS AGAINST HERPES SIMPLEX VIRUS TYPE 1 IN CELL CULTURE. COMPARISON WITH THE ANTIVIRAL ACTIVITY OF PROPOLIS.
Authors	AMOROS,M: SIMOES,CMO: GIRRE,L: SAUVAGER,F: CORMIER,M:
Year	1992
Volume	55
Issue	12

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (7)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GALANGIN	ACTIVE
2	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GALANGIN	ACTIVE
3	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GALANGIN	ACTIVE
4	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GALANGIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAEMPFEROL	ACTIVE
2	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAEMPFEROL	ACTIVE
3	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAEMPFEROL	ACTIVE
4	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAEMPFEROL	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUERCETIN	ACTIVE
2	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUERCETIN	ACTIVE
3	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUERCETIN	ACTIVE
4	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	QUERCETIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHRYSIN	ACTIVE
2	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHRYSIN	ACTIVE
3	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHRYSIN	ACTIVE
4	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHRYSIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	APIGENIN	ACTIVE
2	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	APIGENIN	ACTIVE
3	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	APIGENIN	ACTIVE
4	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	APIGENIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUTEOLIN	ACTIVE
2	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUTEOLIN	ACTIVE
3	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUTEOLIN	ACTIVE
4	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LUTEOLIN	ACTIVE

Apis mellifera (APIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
0	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE

Show SPARQL Queries (1)